These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19425220)

  • 21. Advanced glycation endproducts are deposited in neuronal hyaline inclusions: a study on familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
    Shibata N; Hirano A; Kato S; Nagai R; Horiuchi S; Komori T; Umahara T; Asayama K; Kobayashi M
    Acta Neuropathol; 1999 Mar; 97(3):240-6. PubMed ID: 10090670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid beta 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis.
    Niwa T; Katsuzaki T; Miyazaki S; Momoi T; Akiba T; Miyazaki T; Nokura K; Hayase F; Tatemichi N; Takei Y
    Kidney Int; 1997 Jan; 51(1):187-94. PubMed ID: 8995733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced glycation end products in age-related macular degeneration.
    Ishibashi T; Murata T; Hangai M; Nagai R; Horiuchi S; Lopez PF; Hinton DR; Ryan SJ
    Arch Ophthalmol; 1998 Dec; 116(12):1629-32. PubMed ID: 9869793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis.
    Niwa T; Miyazaki S; Katsuzaki T; Tatemichi N; Takei Y; Miyazaki T; Morita T; Hirasawa Y
    Kidney Int; 1995 Sep; 48(3):771-8. PubMed ID: 7474663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in the advanced glycation end product pentosidine in Bruch's membrane with age.
    Handa JT; Verzijl N; Matsunaga H; Aotaki-Keen A; Lutty GA; te Koppele JM; Miyata T; Hjelmeland LM
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):775-9. PubMed ID: 10067983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer.
    Wendel U; Persson N; Risinger C; Bengtsson E; Nodin B; Danielsson L; Welinder C; Nordin Fredrikson G; Jansson B; Blixt O
    PLoS One; 2018; 13(2):e0191872. PubMed ID: 29420566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N(epsilon)-(carboxymethyl)lysine in atherosclerotic vascular lesions as a marker for local oxidative stress.
    Nerlich AG; Schleicher ED
    Atherosclerosis; 1999 May; 144(1):41-7. PubMed ID: 10381276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis.
    Matsuse T; Ohga E; Teramoto S; Fukayama M; Nagai R; Horiuchi S; Ouchi Y
    J Clin Pathol; 1998 Jul; 51(7):515-9. PubMed ID: 9797728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies against advanced glycation end product Nepsilon-(carboxymethyl)lysine in healthy controls and diabetic patients.
    Vay D; Vidali M; Allochis G; Cusaro C; Rolla R; Mottaran E; Bellomo G; Albano E
    Diabetologia; 2000 Nov; 43(11):1385-8. PubMed ID: 11126407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.
    Imanaga Y; Sakata N; Takebayashi S; Matsunaga A; Sasaki J; Arakawa K; Nagai R; Horiuchi S; Itabe H; Takano T
    Atherosclerosis; 2000 Jun; 150(2):343-55. PubMed ID: 10856526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Creatine plays a direct role as a protein modifier in the formation of a novel advanced glycation end product.
    Miyazaki K; Nagai R; Horiuchi S
    J Biochem; 2002 Oct; 132(4):543-50. PubMed ID: 12359068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of advanced glycation end-products, pentosidine and N(epsilon)-(carboxymethyl)lysine, in doxorubicin-induced cardiomyopathy in rats.
    Moriyama T; Kemi M; Okumura C; Yoshihara K; Horie T
    Toxicology; 2010 Jan; 268(1-2):89-97. PubMed ID: 20004697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen.
    Cefalu WT; Bell-Farrow AD; Wang ZQ; Sonntag WE; Fu MX; Baynes JW; Thorpe SR
    J Gerontol A Biol Sci Med Sci; 1995 Nov; 50(6):B337-41. PubMed ID: 7583789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astrocytic hyaline inclusions contain advanced glycation endproducts in familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutation: immunohistochemical and immunoelectron microscopical analyses.
    Kato S; Horiuchi S; Nakashima K; Hirano A; Shibata N; Nakano I; Saito M; Kato M; Asayama K; Ohama E
    Acta Neuropathol; 1999 Mar; 97(3):260-6. PubMed ID: 10090673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremia.
    Degenhardt TP; Grass L; Reddy S; Thorpe SR; Diamandis EP; Baynes JW
    Kidney Int; 1997 Oct; 52(4):1064-7. PubMed ID: 9328946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD.
    Nakayama M; Kawaguchi Y; Yamada K; Hasegawa T; Takazoe K; Katoh N; Hayakawa H; Osaka N; Yamamoto H; Ogawa A; Kubo H; Shigematsu T; Sakai O; Horiuchi S
    Kidney Int; 1997 Jan; 51(1):182-6. PubMed ID: 8995732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of carboxymethyl-lysine (CML) in human cortical bone.
    Thomas CJ; Cleland TP; Sroga GE; Vashishth D
    Bone; 2018 May; 110():128-133. PubMed ID: 29408699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients.
    Zhang X; Frischmann M; Kientsch-Engel R; Steinmann K; Stopper H; Niwa T; Pischetsrieder M
    Clin Chem Lab Med; 2005; 43(5):503-11. PubMed ID: 15899672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
    Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
    Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overproduction of N(epsilon)-(carboxymethyl)lysine-induced neovascularization in cultured choroidal explant of aged rat.
    Kobayashi S; Nomura M; Nishioka T; Kikuchi M; Ishihara A; Nagai R; Hagino N
    Biol Pharm Bull; 2007 Jan; 30(1):133-8. PubMed ID: 17202673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.